Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) completed a 10-day intensive coached audit for its Good Manufacturing Practices (GMP) Inspectors, aimed at enhancing their practical auditing skills. Supported by WHO-appointed GMP consultants, the training included local manufacturing site visits to address gaps identified in the previous WHO Global Benchmarking Tool audit. Participants gained […]
PPB Unveils 2024 Pharmacovigilance Systems Assessment Findings, Highlighting Progress and Challenges
Nairobi, October 9, 2024 – The Pharmacy and Poisons Board (PPB) presented the findings of the 2024 Pharmacovigilance Systems Assessment on Wednesday, October 9, 2024. This assessment, conducted in collaboration with IGAD, EAC, and supported by MTaPS, covered health facilities, Marketing Authorization Holders, and Public Health Programs. It showed notable progress in monitoring the safety […]
Nairobi, October 9, 2024 – Dr. F.M. Siyoi, the CEO of the Pharmacy and Poisons Board (PPB), chaired the inaugural Partners Forum aimed at enhancing collaboration among partners and stakeholders. During the forum, Dr. Siyoi emphasized the importance of promoting a unified strategic and coordinated approach to regulatory systems to improve access to safe Health […]
Nairobi, October 8, 2024 – Dr. Anthony Toroitich, Director of Corporate Services at the Pharmacy and Poisons Board (PPB), chaired a meeting with representatives from Tonix Pharmaceuticals, USA, during their familiarization visit. The discussions centered on clinical research and market authorization for vaccines. Dr. Toroitich highlighted PPB’s role in ensuring that all clinical trials in […]
Nairobi, 8th October 2024 – The Pharmacy and Poisons Board (PPB) Clinical Trials Division on October 8th, hosted a meeting with representatives from Genetic Immunity, Hungary. Dr. Anthony Toroitich, representing PPB CEO Dr. F. M. Siyoi, highlighted Kenya’s regulatory framework for clinical trials and emphasized PPB’s dedication to advancing healthcare through safe and ethical research. […]
Nairobi, 1st October 2024 – The Strathmore Research and Consultancy Centre (SRCC) at Strathmore University engaged in a fruitful meeting with the Pharmacy and Poisons Board (PPB) on 1st October to explore collaborations focused on advancing the healthcare sector. Key areas of discussion included enhancing regulatory frameworks, fostering partnerships between industry and academia, […]
Nairobi, Kenya – On 26th September 2024 a validation meeting confirmed the feasibility of establishing and implementing bioequivalence (BE) requirements in Kenya. Key stakeholders participated in the discussions, including representatives from the Ministry of Health (MOH), Ministry of Industry, Trade and Investment, Kenya Medical Supplies Authority (KEMSA), Mission for Essential Drugs and Supplies (MEDS), […]
Nairobi, Kenya – On 25th September 2024, the Pharmacy and Poisons Board (PPB), in collaboration with the National Vaccines and Immunization Program (NVIP) and CIHEB-Kenya, disseminated findings from the 2023 COVID-19 Cohort Event Monitoring Study. The results reaffirm that COVID-19 vaccines are a critical tool in curbing the pandemic, with safety data showing the vaccines […]
Nairobi, Kenya – The Pharmacy and Poisons Board (PPB), in collaboration with the Kenya Association of Pharmaceutical Industry (KAPI), marked World Patient Safety Day on Friday, September 13, 2024, at the Arboretum Grounds. The event, themed “Improving Diagnosis for Patient Safety,” gathered key stakeholders from the pharmaceutical sector for an interactive panel discussion, where they […]
Mombasa, Nairobi – The 5th African Union Smart Safety Surveillance (AU-3S) Steering Committee meeting concluded on September 13, reaffirming the commitment to enhance the safety of medical products across Africa. The two-day summit in Mombasa brought together Heads of African National Regulatory Agencies and key stakeholders to strengthen pharmacovigilance systems through collaboration, with a focus […]